Category Archives: Cardiovascular

Walgreens, Cardiovascular Research Foundation to Collaborate on Valvular Heart Disease Trial

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: – retail distribution (90.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.1% of net sales) and International (9.9%). At the end of August 2022, the activity is ensured through […]

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® demonstrates no increased risk in major adverse cardiac events in a large, long-term real-world evidence study

BRENTWOOD, Tenn., Oct. 18, 2023 /PRNewswire/ — Currax Pharmaceuticals LLC (“Currax”) today announced top-line results from a Cardiovascular Health Outcomes Analysis (HOA). This study evaluated the cardiovascular safety of CONTRAVE®/MYSIMBA®, a weight management drug. The real-world study compared CONTRAVE®/MYSIMBA® to a similar product for the purpose of measuring major adverse cardiovascular events (MACE). The primary analysis […]

Menopause, a crucial milestone in a woman’s cardiovascular health

Most women do not anticipate having heart disease. However, the undeniable reality is that cardiovascular disease (CVD) is the leading cause of death among women, both in developed and developing nations. CVD kills one to two-and-a-half times more women in Malaysia than all cancers and yet women are more likely to perceive breast cancer as […]

Walgreens and the Cardiovascular Research Foundation Unite to Improve Recognition and Diagnosis of Valvular Heart Disease for Older Americans

#inform-video-player-1 .inform-embed { margin-top: 10px; margin-bottom: 20px; } #inform-video-player-2 .inform-embed { margin-top: 10px; margin-bottom: 20px; } DEERFIELD, Ill. & NEW YORK–(BUSINESS WIRE)–Oct 18, 2023– Walgreens and the Cardiovascular Research Foundation (CRF) today announced a collaboration to drive forward the PREVUE-VALVE study, a groundbreaking population-based clinical trial that aims to quantify the prevalence of valvular heart […]

Walgreens partners with Cardiovascular Research Foundation on heart disease clinical trials for older seniors

Retail pharmacy giant Walgreens is teaming up with the Cardiovascular Research Foundation to support research into valvular heart disease among older seniors. The two organizations are collaborating on the PREVUE-VALVE study, a population-based clinical trial that aims to quantify the prevalence of valvular heart disease (VHD) among older patients and pave the way for the development of […]

Gill Heart & Vascular Institute to host 10th annual affiliate network meeting in Lexington

LEXINGTON, Ky. (Oct. 18, 2023) — UK HealthCare’s Gill Heart & Vascular Institute Affiliate Network is holding their annual conference on Thursday, Nov. 9, at the Lexington Marriott City Center in downtown Lexington. Conference sessions will focus on the latest advancements and trends in cardiovascular medicine as well as best practices for managing and leading cardiology programs. Heart disease is […]

Menopause Can Be A Risk Factor For Cardiovascular Disease, Finds Study | Bengaluru News

Bengaluru: The International Menopause Society (IMS) has unveiled research ahead of World Menopause Day (October 18), shedding light on female-specific cardiovascular disease (CVD) risk factors. The research paper, titled ‘Reproductive milestones across the lifespan and cardiovascular disease risk in women’, underscores the growing number of milestones in a woman’s life associated with heightened CVD risks. […]

Fort Mill’s Laurel Institute now accepting students for 16-month cardiovascular technology diploma

FORT MILL, S.C. (CN2 NEWS) – Fort Mill now has a new place to learn for anyone looking for an education in the medical field. Its the Laurel Institute of Technology, a 16-month Cardiovascular Technology diploma program which aims to prepare students for a role as a Cardiovascular Technician. The Institute opened recently at 127 […]

SARS-CoV-2 infection boosts inflammation in atherosclerotic plaques

The incidence of acute cardiovascular events, including myocardial infarction and ischemic stroke, is increased in individuals with COVID-19. A study shows that SARS-CoV-2 can directly infect macrophages and foam cells in atherosclerotic plaques and contribute to plaque instability. Four years into the COVID-19 pandemic and with over 770 million confirmed cases worldwide, and despite a […]